# Insulin Diluting Medium for NovoLog

NDC: 0169-2001
Generic name: water injection
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS, SUBCUTANEOUS
Marketing started: 20010827

FDA application: BLA020986

## Active ingredients

- WATER: 1 mL/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-2001"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-2001
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3a1e73a2-3009-40d0-876c-b4cb2be56fc5